IP Library Granted Patent US 11,666,760
Granted Patent B2
US 11,666,760 · App. 17/216,251 · Granted Jun 6, 2023

Cranial nerve stimulation to treat seizure disorders

Inventors: Shivkumar Sabesan (Houston, TX); Steven E. Maschino (Houston, TX)
Assignee: LivaNova USA, Inc.
A61N1/36064A61N1/36053A61N1/36139A61N1/36178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,666,760
App. No.
17/216,251
Granted
Jun 6, 2023
Kind
B2
Abstract

A method includes applying, by an implantable medical device (IMD), stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold and discontinuing the application of stimulation by the IMD when the level of synchrony exceeds a second threshold.

Claims (28)

1. A method comprising:

applying, by an implantable medical device (IMD), stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold; and

discontinuing the application of stimulation by the IMD when the level of synchrony exceeds a second threshold.

2. The method of claim 1 , wherein the first threshold corresponds to a level of synchrony indicative of the onset of a seizure.

3. The method of claim 1 , wherein the second threshold corresponds to a level of synchrony indicative of a non-seizure state.

4. The method of claim 1 , wherein the first threshold and the second threshold correspond to a rate of change of the level of synchrony.

5. The method of claim 1 , wherein the stimulation is applied in a first stimulation mode, the method further comprising applying, by the IMD, stimulation to the cranial nerve of the patient in a second stimulation mode in response to discontinuing the application of stimulation in the first stimulation mode.

6. The method of claim 5 , wherein the first stimulation mode comprises microburst stimulation and the second stimulation mode comprises non-microburst stimulation.

7. The method of claim 5 , wherein the first stimulation mode comprises non-microburst stimulation and the second stimulation mode comprises microburst stimulation.

8. The method of claim 1 , further comprising determining, based on body parameter data collected by one or more sensors positioned on the patient, a first measurement indicative of the level of synchrony.

9. An implantable medical device (IMD) comprising:

a processor; and

a memory device having instructions stored thereon that, when executed by the processor, causes the processor to perform operations comprising:

applying, by one or more electrodes, stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold; and

discontinuing the application of stimulation when the level of synchrony exceeds a second threshold.

10. The IMD of claim 9 , wherein the first threshold corresponds to a level of synchrony indicative of the onset of a seizure.

11. The IMD of claim 9 , wherein the second threshold corresponds to a level of synchrony indicative of a non-seizure state.

12. The IMD of claim 9 , wherein the first threshold and the second threshold correspond to a rate of change of the level of synchrony.

13. The IMD of claim 9 , wherein the stimulation is applied in a first stimulation mode, the operations further comprising applying, by the one or more electrodes, stimulation to the cranial nerve of the patient in a second stimulation mode in response to discontinuing the application of stimulation in the first stimulation mode.

14. The IMD of claim 13 , wherein the first stimulation mode comprises microburst stimulation and the second stimulation mode comprises non-microburst stimulation.

15. The IMD of claim 13 , wherein the first stimulation mode comprises non-microburst stimulation and the second stimulation mode comprises microburst stimulation.

16. The IMD of claim 9 , the operations further comprising determining, based on body parameter data collected by one or more sensors positioned on the patient, a first measurement indicative of the level of synchrony.

17. A computer-readable storage medium storing instructions thereon that, when executed by a processor of an implantable medical device (IMD), cause the IMD to:

apply stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold; and

discontinue the application of stimulation when the level of synchrony exceeds a second threshold.

18. The computer-readable storage medium of claim 17 , wherein the first threshold corresponds to a level of synchrony indicative of the onset of a seizure and wherein the second threshold corresponds to a level of synchrony indicative of a non-seizure state.

19. The computer-readable storage medium of claim 17 , wherein the first threshold and the second threshold correspond to a rate of change of the level of synchrony.

20. The computer-readable storage medium of claim 17 , wherein the stimulation is applied in a first stimulation mode, the instructions further causing the IMD to apply stimulation to the cranial nerve of the patient in a second stimulation mode in response to discontinuing the application of stimulation in the first stimulation mode.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2023
From: SABESAN, SHIVKUMAR; MASCHINO, STEVEN E.
To: CYBERONICS, INC.
Reel/Frame 063416/0335 →
CHANGE OF NAME Recorded Apr 24, 2023
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 063424/0353 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
Continuity (5)
Continuation 16184789 · Nov 8, 2018
Continuation 14316258 · Jun 26, 2014
Provisional Application 61840461 · Jun 28, 2013
Provisional Application 61888303 · Oct 8, 2013
Related Publication 20210213289A1 · Jul 15, 2021